ClinicalTrials.Veeva

Menu

Cancer Stem Cells in Multiple Myeloma

A

Ankara University

Status

Completed

Conditions

Multiple Myeloma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.

Full description

The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their prognostic value and check for any relationship between cancer stem cell quantification and chemotherapy response are main aims of this study.

Enrollment

96 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • New Diagnosed or Relapsed Multiple Myeloma
  • Routine Bone Marrow Aspiration will be done

Exclusion criteria

  • Bone Marrow Aspiration is not Needed

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems